Journal
ISCIENCE
Volume 23, Issue 6, Pages -Publisher
CELL PRESS
DOI: 10.1016/j.isci.2020.101201
Keywords
-
Categories
Funding
- NCI Genitourinary Bladder SPORE Grant [P50CA 91846]
Ask authors/readers for more resources
We report a comprehensive molecular analysis of 34 cases of small cell carcinoma (SCC) and 84 cases of conventional urothelial carcinoma (UC), with The Cancer GenomeAtlas cohort of 408 conventional UCbladder cancers used as the reference. SCCs showed mutational landscapes characterized by nearly uniforminactivation of TP53 and were dominated by Sanger mutation signature 3 associated with loss of BRCA1/2 function. SCCs were characterized by downregulation of luminal and basal markers and were referred to as double-negative. Transcriptome analyses indicated that SCCs displayed lineage plasticity driven by a urothelial-to-neural phenotypic switch with a dysregulated epithelial-to-mesenchymal transition network. SCCs were depleted of immune cells, and expressed high levels of the immune checkpoint receptor, adenosine receptor A2A(ADORA2A), which is a potent inhibitor o fimmune infiltration. Our observations have important implications for the prognostication and development of more effective therapies for this lethal bladder cancer variant.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available